SEC Form 4/A · accession 0001104659-15-022207
ARRAY BIOPHARMA INC · ARRY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
John R Moore
Officer — VP, General Counsel
Period of report
Mar 1, 2015
Accepted (ET)
Mar 24, 2015 · 8:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100412
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 15,384 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This amended Form 4 is filed to correct the Reporting Person's holdings after the transactions reported on the Form 4 filed March 4, 2015. All other data reported was correct.